Basic Research
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 28, 2006; 12(32): 5160-5167
Published online Aug 28, 2006. doi: 10.3748/wjg.v12.i32.5160
Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer
Alexander Huether, Michael Höpfner, Andreas P Sutter, Viola Baradari, Detlef Schuppan, Hans Scherübl
Alexander Huether, Michael Höpfner, Andreas P Sutter, Viola Baradari, Hans Scherübl, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Medical Clinic I, Gastroenterology/Infectious Diseases/Rheumatology, Berlin, Germany
Detlef Schuppan, Harvard Medical School, Beth Israel Deaconess Medical Center, Division of Gastroenterology and Hepatology, Boston, United States
Author contributions: All authors contributed equally to the work.
Supported by Deutsche Forschungsgemeinschaft (DFG), Deutsche Krebshilfe and Sonnenfeld-Stiftung Berlin
Correspondence to: Professor, Dr. Hans Scherübl, Charité- Universitätsmedizin Berlin, Campus Benjamin Franklin, Medical Clinic I, Hindenburgdamm 30, 12200 Berlin, Germany. hans.scherübl@charite.de
Telephone: +49-30-84453534 Fax: +49-30-84454481
Received: December 3, 2005
Revised: January 8, 2006
Accepted: January 14, 2006
Published online: August 28, 2006
Core Tip